ProCE Banner Activity

WHO VigiBase Analysis: Thromboembolic Safety of Tofacitinib, Baricitinib in Rheumatoid Arthritis

Slideset Download
Conference Coverage
Analysis of individual case safety reports in worldwide pharmacovigilance database examines thromboembolic events with tofacitinib and baricitinib.

Released: July 01, 2020

Expiration: June 30, 2021

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Gilead Sciences, Inc.